971
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Managing dry skin in patients with comorbidities or with advanced age: unmet needs and roles for products containing potential emollient-plus ingredients

, , , , , & show all
Article: 2326171 | Received 12 Dec 2023, Accepted 27 Feb 2024, Published online: 02 Apr 2024

References

  • Augustin M, Kirsten N, Körber A, et al. Prevalence, predictors and comorbidity of dry skin in the general population. J Eur Acad Dermatol Venereol. 2019;33(1):1–9. doi:10.1111/jdv.15157.
  • Jiang Q, Wang Y, Liu Y, et al. Prevalence and associated ­factors of dry skin among older inpatients in hospitals and nursing homes: a multicenter cross-sectional study. Int J Nurs Stud. 2022;135:104358. doi:10.1016/j.ijnurstu.2022.104358.
  • Yosipovitch G, Misery L, Proksch E, et al. Skin barrier damage and itch: review of mechanisms, topical management and future directions. Acta Derm Venereol. 2019;99(13):1201–1209. doi:10.2340/00015555-3296.
  • Augustin M, Wilsmann-Theis D, Körber A, et al. Diagnosis and treatment of xerosis cutis - a position paper. J Dtsch Dermatol Ges. 2019;17(S7):3–33. doi:10.1111/ddg.13906.
  • Proksch E, Berardesca E, Misery L, et al. Dry skin management: practical approach in light of latest research on skin structure and function. J Dermatolog Treat. 2020;31(7):716–722. doi:10.1080/09546634.2019.1607024.
  • Zhang J, Loman L, Oldhoff M, et al. Association between moderate to severe atopic dermatitis and lifestyle factors in the dutch general population. Clin Exp Dermatol. 2022;47(8):1523–1535. doi:10.1111/ced.15212.
  • Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38(3):337–342. doi:10.1038/ng1743.
  • Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):792–799. doi:10.1016/j.jaci.2014.06.014.
  • Thyssen JP, Rinnov MR, Vestergaard C. Disease mechanisms in atopic dermatitis: a review of aetiological factors. Acta Derm Venereol. 2020;100(12):adv00162. doi:10.2340/00015555-3512.
  • Alinaghi F, Bennike NH, Egeberg A, et al. Prevalence of contact allergy in the general population: a systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77–85. doi:10.1111/cod.13119.
  • Bauer A, Pesonen M, Brans R, et al. Occupational contact allergy: the european perspective - analysis of patch test data from ESSCA between 2011 and 2020. Contact Dermatitis. 2023;88(4):263–274. doi:10.1111/cod.14280.
  • Thyssen JP, Schuttelaar MLA, Alfonso JH, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86(5):357–378. doi:10.1111/cod.14035.
  • Hahnel E, Blume-Peytavi U, Trojahn C, et al. Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study. BMJ Open. 2017;7(9):e018283. doi:10.1136/bmjopen-2017-018283.
  • Lichterfeld-Kottner A, Lahmann N, Blume-Peytavi U, et al. Dry skin in home care: a representative prevalence study. J Tissue Viability. 2018;27(4):226–231. doi:10.1016/j.jtv.2018.07.001.
  • Zhang S, Duan E. Fighting against skin aging: the way from bench to bedside. Cell Transplant. 2018;27(5):729–738. doi:10.1177/0963689717725755.
  • Kruglova LS, Lvov AN, Araviyskaya ER, et al. Practical issues of use of emollients in management of patients with xerosis: resolution of the panel of experts from russia, Kazakhstan and the republic of Belarus. Kremline Med. 2021;4:103–115.
  • Lacarrubba F, Verzì AE, Dinotta F, et al. 10% Urea cream in senile xerosis: clinical and instrumental evaluation. J Cosmet Dermatol. 2021;20(Suppl 1):5–8. doi:10.1111/jocd.14093.
  • Celleno L. Topical urea in skincare: a review. Dermatol Ther. 2018;31(6):e12690. doi:10.1111/dth.12690.
  • Piquero-Casals J, Morgado-Carrasco D, Granger C, et al. Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties. Dermatol Ther (Heidelb). 2021;11(6):1905–1915. doi:10.1007/s13555-021-00611-y.
  • Lima AL, Illing T, Schliemann S, et al. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017;18(4):541–553. doi:10.1007/s40257-017-0275-z.
  • Pavicic T, Korting HC. Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management. J Dtsch Dermatol Ges. 2006;4(11):935–941. doi:10.1111/j.1610-0387.2006.06123.x.
  • Lechner A, Akdeniz M, Tomova-Simitchieva T, et al. Comparing skin characteristics and molecular markers of xerotic foot skin between diabetic and non-diabetic subjects: an exploratory study. J Tissue Viability. 2019;28(4):200–209. doi:10.1016/j.jtv.2019.09.004.
  • Swarna SS, Aziz K, Zubair T, et al. Pruritus associated with chronic kidney disease: a comprehensive literature review. Cureus. 2019;11(7):e5256. doi:10.7759/cureus.5256.
  • Simões FV, Santos VO, Silva RND, et al. Effectiveness of skin protectors and calendula officinalis for prevention and treatment of radiodermatitis: an integrative review. Rev Bras Enferm. 2020;73(suppl 5):e20190815. doi:10.1590/0034-7167-2019-0815.
  • Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85(4):e209–e233. doi:10.1016/j.jaad.2021.02.082.
  • de Oliveira ECV, da Motta VRV, Pantoja PC, et al. Actinic keratosis - review for clinical practice. Int J Dermatol. 2019;58(4):400–407. doi:10.1111/ijd.14147.
  • Mishra SC, Chhatbar KC, Kashikar A, et al. Diabetic foot. BMJ. 2017;359:j5064. doi:10.1136/bmj.j5064.
  • Tajalli F, Mirahmadi SM, Mozafarpoor S, et al. Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: a cross-sectional study of 49 patients. Dermatol Ther. 2021;34(4):e15015. doi:10.1111/dth.15015.
  • Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol. 2014;9(1):201–218. doi:10.2215/CJN.05900513.
  • Wulczyn KE, Rhee EP, Myint L, et al. Incidence and risk factors for pruritus in patients with nondialysis CKD. Clin J Am Soc Nephrol. 2023;18(2):193–203. doi:10.2215/CJN.09480822.
  • Perillo B, Di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192–203. doi:10.1038/s12276-020-0384-2.
  • Nakai K, Tsuruta D. What are reactive oxygen species, free radicals, and oxidative stress in skin diseases? Int J Mol Sci. 2021;22(19):10799. doi:10.3390/ijms221910799.
  • Finkelstein S, Kanee L, Behroozian T, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer. 2022;30(6):4663–4674. doi:10.1007/s00520-022-06829-6.
  • Layer K, Layer JP, Glasmacher AR, et al. Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the german-speaking radiation oncology community. Strahlenther Onkol. 2023;199(10):891–900. doi:10.1007/s00066-023-02074-w.
  • Layer JP, Layer K, Glasmacher AR, et al. Pharmaceutical management of acute radiation dermatitis in the german speaking radiation oncology community. J Dtsch Dermatol Ges. 2024;22(2):198–207. doi:10.1111/ddg.15279.
  • Grandahl K, Olsen J, Friis KBE, et al. Photoaging and actinic keratosis in danish outdoor and indoor workers. Photodermatol Photoimmunol Photomed. 2019;35(4):201–207. doi:10.1111/phpp.12451.
  • Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema – part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022;36(11):1904–1926. doi:10.1111/jdv.18429.
  • Araviiskaia E, Pincelli C, Sparavigna A, et al. The role of a ­novel generation of emollients, ‘emollients plus’, in atopic dermatitis. Clin Cosmet Investig Dermatol. 2022;15:2705–2719. doi:10.2147/CCID.S389697.
  • Vendrely V, Mayor-Ibarguren A, Stennevin A, et al. An emollient plus balm is useful for the management of xerosis in patients treated for cancer: a real-world, prospective, observational, multicenter study. Dermatol Ther (Heidelb). 2022;12(3):683–699. doi:10.1007/s13555-022-00685-2.
  • Patsatsi A, Vakirlis E, Kanelleas A, et al. Effect of a novel "emollient plus" formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients. Eur J Dermatol. 2023;33(2):137–146. doi:10.1684/ejd.2023.4449.
  • Magnolo N, Jaenicke T, Tsianakas A, et al. Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2023;37 Suppl 5:18–26. doi:10.1111/jdv.18949.
  • Zelenkova H, Kerob D, Salah S, et al. Impact of daily use of emollient ‘plus’ on corticosteroid consumption in patients with atopic dermatitis: an open, randomized controlled study. J Eur Acad Dermatol Venereol. 2023;37 Suppl 5:27–34. doi:10.1111/jdv.18947.
  • Stettler H, de Salvo R, Brandt M, et al. Performance and acceptability of a new dexpanthenol-containing hand cream in subjects with sensitive and very dry skin: a randomized controlled study. Cosmetics. 2022;9(3):44. doi:10.3390/cosmetics9030044.
  • Stettler H, Doarika A, Reber F. Performance, acceptability and tolerability of a new dexpanthenol-containing emollient in the care of dry skin in adult diabetics. EADV. Virtual Conference. 2020.
  • Stettler H, de Salvo R, Olsavszky R, et al. Performance and tolerability of a new topical dexpanthenol-containing emollient line in subjects with dry skin: results from three randomized studies. Cosmetics. 2021;8(1):18. doi:10.3390/cosmetics8010018.
  • Schmid DA, Domingues MP, Nanu A, et al. Exploratory evaluation of tolerability, performance, and cosmetic acceptance of dexpanthenol-containing dermo-cosmetic wash and sun-care products for tattoo aftercare. Health Sci Rep. 2022;5(4):e635. doi:10.1002/hsr2.635.
  • ClinicalTrials.gov. A clinical study of adherence to methylprednisolone aceponate in different carriers (AD-HERE) [Internet]. https://clinicaltrials.gov/ct2/show/NCT04016025.
  • ClinicalTrials.gov. A study to gain information how well dexpanthenol dermal spray helps the skin to recover after a peeling in the external genital area of women [Internet]. https://clinicaltrials.gov/ct2/show/NCT03853512.
  • ClinicalTrials.gov. A study to gain information how well dexpanthenol dermal spray helps the skin to recover after laser hair removal in the groin and intimate area [Internet]. https://clinicaltrials.gov/ct2/show/NCT03853525.
  • Stettler H, Kurka P, Kandzora J, et al. A new topical panthenol-containing emollient for maintenance treatment of childhood atopic dermatitis: results from a multicenter prospective study. J Dermatolog Treat. 2017;28(8):774–779. doi:10.1080/09546634.2017.1328938.
  • Heise R, Skazik C, Marquardt Y, et al. Dexpanthenol modulates gene expression in skin wound healing in vivo. Skin Pharmacol Physiol. 2012;25(5):241–248. doi:10.1159/000341144.
  • ClinicalTrials.gov. A study to gain information how well dexpanthenol dermal cream helps the face skin to recover after cosmetic lasering [Internet]. https://clinicaltrials.gov/ct2/show/NCT03852563.
  • ClinicalTrials.gov. A study to gain information how well dexpanthenol dermal spray helps the face skin to recover after cosmetic lasering [Internet]. https://clinicaltrials.gov/ct2/show/NCT03853538.
  • Heise R, Schmitt L, Huth L, et al. Accelerated wound healing with a dexpanthenol-containing ointment after fractional ablative CO2 laser resurfacing of photo-damaged skin in a randomized prospective clinical trial. Cutan Ocul Toxicol. 2019;38(3):274–278. doi:10.1080/15569527.2019.1597879.
  • ClinicalTrials.gov. Comparison of the effect of Vaseline and Bepanthen® "Wund- und Heilsalbe" on the wound healing following laser therapy (CO2) [Internet]. https://clinicaltrials.gov/ct2/show/NCT03095872.
  • Peltier E, de Salvo R, Ehret A, et al. Evaluation of a 5% dexpanthenol-containing ointment for the treatment of infant irritant diaper dermatitis through the lens of the caregiver-A real-world data observational study. Health Sci Rep. 2023;6(1):e1033. doi:10.1002/hsr2.1033.
  • Peltier E, Trapp S, de Salvo R, et al. A new dexpanthenol-containing liquid cleanser for atopic-prone skin: results from two prospective clinical studies evaluating cutaneous tolerability, moisturization potential, and effects on barrier function. J Cosmet Dermatol. 2022;21(9):3859–3866. doi:10.1111/jocd.15252.
  • Proksch E, de Bony R, Trapp S, et al. Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017;28(8):766–773. doi:10.1080/09546634.2017.1325310.
  • Gorski J, Proksch E, Baron JM, et al. Dexpanthenol in wound healing after medical and cosmetic interventions (postprocedure wound healing). Pharmaceuticals (Basel). 2020;13(7):138. doi:10.3390/ph13070138.
  • Reinartz G, Eich HT, Pohl F, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). DEGRO practical guidelines for the radiotherapy of non-malignant disorders - part IV: symptomatic functional disorders. Strahlenther Onkol. 2015;191(4):295–302. doi:10.1007/s00066-014-0789-8.